Field dossier · from the corpus

Lymphoma

0predicted collisions

Where this field is predicted to collide

No open collisions on this field in the current run.

Most cited work

Engineering strategies to overcome the current roadblocks in CAR T cell therapy

20191,492 citationsDOI ↗

Long-term outcomes following CAR T cell therapy: what we know so far

20231,363 citationsDOI ↗

Emerging Cellular Therapies for Cancer

2018402 citationsDOI ↗

Signals

3

Papers · in corpus

3.3k

Citations · corpus total

0.0%

Recent share · since 2024

2018–2023

Span · publication years

Who is doing the work

Consorci Institut D'Investigacions Biomediques August Pi I SunyerES1
Parker Institute for Cancer ImmunotherapyUS1
University of California, San FranciscoUS1
Howard Hughes Medical InstituteUS1
Center for Cancer ResearchUS1
National Cancer InstituteUS1
Emory UniversityUS1
University of PennsylvaniaUS1

Most published researchers

Sònia Guedan1
Marco Ruella1
Carl H. June1
Kathryn M. Cappell1
James N. Kochenderfer1
Sarwish Rafiq1

Already lives beside

Fields this one already co-publishes with. A predicted collision is a departure from this neighbourhood, not an extension of it.

Immunology3 Immunotherapy2 Genetically engineered1 Synthetic biology1 Multiple myeloma1 Malignancy1 CD191 B cell1 Oncology1 Immune system1

Lymphoma · Raz0r Prism